QC
ULBI icon

Quadrature Capital’s Ultralife ULBI Stock Holding History

Quadrature Capital’s Portfolio ULBI Stock Details ULBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,458
Closed -$84.1K – 1667
2025
Q3 		$84.1K Buy
+12,458
New +$94.4K ﹤0.01% 897
2024
Q4 		– Sell
-18,705
Closed -$169K – 1422
2024
Q3 		$169K Sell
18,705
-5,279
-22% -$54.5K ﹤0.01% 797
2024
Q2 		$254K Buy
23,984
+1,404
+6% +$14.9K ﹤0.01% 871
2024
Q1 		$200K Buy
+22,580
New +$184K ﹤0.01% 1045
2021
Q3 		– Sell
-13,206
Closed -$110K – 1059
2021
Q2 		$110K Buy
13,206
+2,306
+21% +$19.9K ﹤0.01% 886
2021
Q1 		$90K Buy
+10,900
New +$77.3K ﹤0.01% 824

Other funds holding ULBI

VWA
Visionary Wealth Advisors O'fallon, Illinois $2.26B AUM 19.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
THC
Truffle Hound Capital Bethesda, Maryland $386M AUM 57.88% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Quadrature Capital's ULBI Position: Q4 2025 in Review

Quadrature Capital sold out of Ultralife (ULBI) in Q4 2025, closing a stake of 12,458 shares — an estimated $84.1K sold.

Quadrature Capital first reported a position in ULBI in Q1 2021 and held it in 6 quarters. The position peaked at $254K in Q2 2024. 60 funds tracked by Wall St. Rank hold ULBI as of Q4 2025.

  • Quadrature Capital reported no remaining Ultralife position as of Q4 2025 after selling out during the quarter.
  • Quadrature Capital sold 12,458 Ultralife shares in Q4 2025, an estimated $84.1K.
  • Quadrature Capital first reported a position in Ultralife in Q1 2021 and held it in 6 quarters.
  • Quadrature Capital's Ultralife position peaked at $254K in Q2 2024.
  • 60 funds tracked by Wall St. Rank held Ultralife as of Q4 2025.

Based on Quadrature Capital's 13F filing for Q4 2025, filed 17 Feb 2026.